Jolmo Capital

Total investments

37

Average round size

22M

Portfolio companies

36

Rounds per year

1.85

Lead investments

8

Follow on index

0.03

Exits

6

Stages of investment
Private Equity
Areas of investment
BiotechnologyInformation TechnologyInformation ServicesHealth CareRoboticsManufacturingMedical DeviceMedicalPersonal HealthPharmaceutical

Summary

The main office of represented VC is situated in the Nanjing. The fund was located in Asia if to be more exact in China.

Among the most successful fund investment fields, there are Consumer, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Yunji Technology, Star chain technology, Dynosense.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Jolmo Capital, startups are often financed by Tencent Holdings, SMC Capital China, Lanting Capital. The meaningful sponsors for the fund in investment in the same round are Wilson Sonsini Goodrich & Rosati, WI Harper Group, Tianxing Capital. In the next rounds fund is usually obtained by SMC Capital China, Plug and Play, GF Xinde Investment Management.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Jolmo Capital performs on 15 percentage points less the average number of lead investments.

Show more

Investments analytics

Analytics

Total investments
37
Lead investments
8
Exits
6
Rounds per year
1.85
Follow on index
0.03
Investments by industry
  • Health Care (11)
  • Medical (9)
  • Biotechnology (7)
  • Manufacturing (6)
  • Medical Device (4)
  • Show 54 more
Investments by region
  • China (34)
  • Japan (1)
  • United States (1)
Peak activity year
2022
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
38M
Group Appearance index
0.70
Avg. company exit year
4
Avg. multiplicator
1.94
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Tsingke Biotechnology 05 Dec 2022 Biotechnology, Health Care, Medical Early Stage Venture 61M Beijing, Beijing, China
Tuohang Technology 29 Apr 2024 Early Stage Venture Chongqing, Jiangjin, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.